B – Single IRBs in multisite trials

Klitzman R, Pivovarova E, Lidz CW. Single IRBs in multisite trials. Question posed by the new NIH policy. JAMA 2017;317(20):2061-2062
(doi: 10.1001/jama.2017.4624)

The National Institutes of Health (NIH) announced a new policy (effective September 25, 2017) to mandate that nonexempt multisite research with humans funded by the NIH be reviewed by a single institutional review boards (IRBs). Underlying the policy is the belief that the use of single IRBs for multisite studies avoids duplicate and possibly conflicting IRB reviews and thereby streamlines and accelerates the review process.